Coadministration of proton pump inhibitors may decrease the efficacy of capecitabine in metastatic breast cancer patients

被引：0
|
作者：
Altundag, Kadri [1 ]
机构：
[1] Hacettepe Univ, Canc Inst, Dept Oncol, TR-06100 Ankara, Turkey
来源：
JOURNAL OF BUON | 2017年 / 22卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：559 / 560
页数：2
相关论文
共 50 条
  • [1] Proton pump inhibitors decrease efficacy of palbociclib in patients with metastatic breast
    Criado, Javier alvarez
    Aunon, Pilar Zamora
    Marin, Virginia Martinez
    Cabetas, Macarena GarciaTrevijano
    Sanchez, Victoria Lucia Collada
    Arranz, Enrique Espinosa
    Romero-Garrido, Jose Antonio
    Benedi-Gonzalez, Juana
    Almiron, Mariana Diaz
    Ambrosio, Alicia Herrero
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [2] Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?
    Odabas, Hatice
    Dogan, Akif
    Ozcelik, Melike
    Yildirim, Sedat
    Ozkerim, Ugur
    Turan, Nedim
    Yildirim, Mahmut Emre
    Gumus, Mahmut
    MEDICINA-LITHUANIA, 2023, 59 (03):
  • [3] Coadministration of Proton Pump Inhibitors and the Efficacy of Capecitabine in Patients With Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater
    Altundag, Kadri
    CANCER, 2017, 123 (06) : 1073 - 1073
  • [4] Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study
    Kadir Eser
    Arif Hakan Önder
    Emel Sezer
    Timuçin Çil
    Ali İnal
    Banu Öztürk
    Vehbi Erçolak
    Berna Bozkurt Duman
    Halil Çelik
    Tolga Köşeci
    Oğuzhan Kesen
    BMC Cancer, 22
  • [5] Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study
    Eser, Kadir
    Onder, Arif Hakan
    Sezer, Emel
    Cil, Timucin
    Inal, Ali
    Ozturk, Banu
    Ercolak, Vehbi
    Duman, Berna Bozkurt
    Celik, Halil
    Koseci, Tolga
    Kesen, Oguzhan
    BMC CANCER, 2022, 22 (01)
  • [6] Efficacy of capecitabine when used concomitantly with proton pump inhibitors in cancer patients: a systematic review
    D. Viñal
    N. Rodriguez-Salas
    P. Perez-Wert
    O. Higuera
    I. Ghanem
    J. Feliu
    Clinical and Translational Oncology, 2020, 22 : 1288 - 1294
  • [7] Efficacy of capecitabine when used concomitantly with proton pump inhibitors in cancer patients: a systematic review
    Vinal, D.
    Rodriguez-Salas, N.
    Perez-Wert, P.
    Higuera, O.
    Ghanem, I
    Feliu, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (08): : 1288 - 1294
  • [8] Coadministration of clopidogrel and proton pump inhibitors
    Keller, David L.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2011, 78 (05) : 284 - 284
  • [9] Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma
    Iida, Keitaro
    Naiki, Taku
    Etani, Toshiki
    Nagai, Takashi
    Sugiyama, Yosuke
    Isobe, Teruki
    Aoki, Maria
    Nozaki, Satoshi
    Noda, Yusuke
    Shimizu, Nobuhiko
    Tomiyama, Nami
    Gonda, Masakazu
    Kamiya, Hiroyuki
    Kubota, Hiroki
    Nakane, Akihiro
    Ando, Ryosuke
    Kawai, Noriyasu
    Yasui, Takahiro
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [10] Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma
    Keitaro Iida
    Taku Naiki
    Toshiki Etani
    Takashi Nagai
    Yosuke Sugiyama
    Teruki Isobe
    Maria Aoki
    Satoshi Nozaki
    Yusuke Noda
    Nobuhiko Shimizu
    Nami Tomiyama
    Masakazu Gonda
    Hiroyuki Kamiya
    Hiroki Kubota
    Akihiro Nakane
    Ryosuke Ando
    Noriyasu Kawai
    Takahiro Yasui
    Scientific Reports, 14
12345